The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Christopher & Banks Corp

NYSE: CBK
Last

(U.S.) $2.06

Today's change0.00 0.00%
Updated August 29 4:01 PM EDT. Delayed by at least 15 minutes.
 

Christopher & Banks Corp

NYSE: CBK
Last

(U.S.) $2.06

Today's change0.00 0.00%
Updated August 29 4:01 PM EDT. Delayed by at least 15 minutes.

Christopher & Banks Corp closed at (U.S.)$2.06.

Over the last five days, shares are unchanged, but have gained 24.85% over the last year to date. This security has outperformed the S&P 500 by 10.84% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $2.06
  • High--
  • Low--
  • Bid / Ask(U.S.) $0.00 / (U.S.) $2.17
  • YTD % change+24.85%
  • Volume0
  • Average volume (10-day)158,882
  • Average volume (1-month)152,585
  • Average volume (3-month)292,001
  • 52-week range(U.S.) $0.96 to (U.S.) $3.02
  • Beta2.78
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.30
Updated August 29 4:01 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-12.19%

Christopher & Banks Corp has a net profit margin of -12.19%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:Cyclical Consumer Goods & ServicesIndustry:Retail - Apparel & Accessories
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedApr 30, 201604/30/2016Jan 30, 201601/30/2016Oct 31, 201510/31/2015Aug 01, 201508/01/2015
Revenue1009510494
Total other revenue--------
Total revenue1009510494
Gross profit38293731
Total cost of revenue62656763
Total operating expense10110210396
Selling / general / administrative35333430
Research & development--------
Depreciation / amortization3333
Interest expense (income), net operating--------
Unusual expense (income)0000
Other operating expenses, total--------
Operating income-1-70-2
Interest income (expense), net non-operating0------
Gain (loss) on sale of assets--------
Other--------
Income before tax0-70-2
Income after tax0-470-1
Income tax, total0391-1
Net income0-470-1
Total adjustments to net income--------
Net income before extra. items0-470-1
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items0-470-1
Inc. avail. to common incl. extra. items0-470-1
Diluted net income0-470-1
Dilution adjustment--------
Diluted weighted average shares37373737
Diluted EPS excluding extraordinary itemsvalue per share0.00-1.26-0.01-0.02
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.00-1.26-0.01-0.02